Amiodarone-induced sinoatrial block

Area of Science:

• Pediatric Cardiology
• Electrophysiology
• Pharmacology

Background:

• Primary cardiomyopathy and supraventricular tachycardia are significant pediatric cardiac conditions.
• Wolff-Parkinson-White syndrome requires careful management due to arrhythmia risks.
• Amiodarone is a common antiarrhythmic drug used in pediatric patients.

Observation:

• A 5-year-old boy with pre-existing cardiomyopathy, Wolff-Parkinson-White syndrome, and supraventricular tachycardia was treated with amiodarone.
• Chronic amiodarone administration led to the development of sinoatrial block in this patient.

Findings:

• Dosage reduction of amiodarone successfully reversed the sinoatrial block.
• The patient, however, continued to exhibit asymptomatic sinus bradycardia after the dosage adjustment.

Implications:

• This case highlights the potential for amiodarone-induced sinoatrial node dysfunction in pediatric patients.
• Careful dose titration of amiodarone is crucial for managing arrhythmias while minimizing adverse cardiac effects.
• Understanding drug-induced conduction abnormalities is vital for optimizing treatment strategies in young patients with complex cardiac conditions.